30 years on: how the neurodevelopmental hypothesis of schizophrenia morphed into the developmental risk factor model of psychosis

RM Murray, V Bhavsar, G Tripoli… - Schizophrenia …, 2017 - academic.oup.com
At its re-birth 30 years ago, the neurodevelopment hypothesis of schizophrenia focussed on
aberrant genes and early neural hazards, but then it grew to include ideas concerning …

An integrative perspective on the role of dopamine in schizophrenia

TV Maia, MJ Frank - Biological psychiatry, 2017 - Elsevier
We propose that schizophrenia involves a combination of decreased phasic dopamine
responses for relevant stimuli and increased spontaneous phasic dopamine release. Using …

Cannabis-associated psychosis: Neural substrate and clinical impact

RM Murray, A Englund, A Abi-Dargham, DA Lewis… - …, 2017 - Elsevier
Prospective epidemiological studies have consistently demonstrated that cannabis use is
associated with an increased subsequent risk of both psychotic symptoms and …

[HTML][HTML] The role of trauma and stressful life events among individuals at clinical high risk for psychosis: A review

D Mayo, S Corey, LH Kelly, S Yohannes… - Frontiers in …, 2017 - frontiersin.org
The experience of childhood trauma (CT) and stressful life events (SLEs) is associated with
subsequent development of a variety of mental health conditions, including psychotic illness …

Extended difficulties following the use of psychedelic drugs: A mixed methods study

J Evans, OC Robinson, EK Argyri, S Suseelan… - Plos one, 2023 - journals.plos.org
Long-term adverse experiences following psychedelic use can persist for weeks, months, or
even years, and are relatively unexplored in psychedelic research. Our convergent mixed …

Amphetamine-induced psychosis-a separate diagnostic entity or primary psychosis triggered in the vulnerable?

JG Bramness, ØH Gundersen, J Guterstam, EB Rognli… - BMC psychiatry, 2012 - Springer
Use of amphetamine and methamphetamine is widespread in the general population and
common among patients with psychiatric disorders. Amphetamines may induce symptoms of …

From psychiatry to neurology: Psychedelics as prospective therapeutics for neurodegenerative disorders

U Kozlowska, C Nichols, K Wiatr… - Journal of …, 2022 - Wiley Online Library
The studies of psychedelics, especially psychedelic tryptamines like psilocybin, are rapidly
gaining interest in neuroscience research. Much of this interest stems from recent clinical …

Propranolol's effects on the consolidation and reconsolidation of long-term emotional memory in healthy participants: a meta-analysis

MH Lonergan, LA Olivera-Figueroa, RK Pitman… - Journal of Psychiatry and …, 2013 - jpn.ca
Background: Considering the pivotal role of negative emotional experiences in the
development and persistence of mental disorders, interfering with the consolidation …

d-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: mechanism of action and potential therapeutic applications in mood disorders

D De Gregorio, JP Enns, NA Nuñez, L Posa… - Progress in brain …, 2018 - Elsevier
Depression and anxiety are psychiatric diagnoses commonly associated with low quality of
life and low percentage of responsiveness by patients treated with currently available drugs …

The thalamus in psychosis spectrum disorder

A Anticevic, MM Halassa - Frontiers in Neuroscience, 2023 - frontiersin.org
Psychosis spectrum disorder (PSD) affects 1% of the world population and results in a
lifetime of chronic disability, causing devastating personal and economic consequences …